# An Exploratory Clinical Study of BC006 in Patients With Advanced Solid Tumors

> **NCT05212896** · PHASE1 · UNKNOWN · sponsor: **Dragonboat Biopharmaceutical Company Limited** · enrollment: 90 (estimated)

## Conditions studied

- Advanced Solid Tumors (Including GCTTS)

## Interventions

- **DRUG:** BC006

## Key facts

- **NCT ID:** NCT05212896
- **Lead sponsor:** Dragonboat Biopharmaceutical Company Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-11-26
- **Primary completion:** 2024-12
- **Final completion:** 2024-12
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2022-01-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05212896

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05212896, "An Exploratory Clinical Study of BC006 in Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05212896. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*